title: Entinostat plus exemestane has activity in ER+ advanced breast cancer.
abstract: Adding entinostat to exemestane improves survival in women with ER(+) advanced breast cancer.
mesh_terms: D000730:Androstadienes / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D047072:Aromatase Inhibitors / Q000008:administration & dosage; D001549:Benzamides / Q000008:administration & dosage*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D011725:Pyridines / Q000008:administration & dosage*; D011960:Receptors, Estrogen / Q000235:genetics
chemical_list: D000730:Androstadienes; D047072:Aromatase Inhibitors; D001549:Benzamides; D011725:Pyridines; D011960:Receptors, Estrogen; C118739:entinostat; C056516:exemestane